A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates

P. van den Berg*, P. M. M. van Haard, E. van der Veer, P. P. Geusens, J. P. van den Bergh, D. H. Schweitzer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)813-824
Number of pages12
JournalOsteoporosis International
Volume29
Issue number4
DOIs
Publication statusPublished - 1 Apr 2018

Keywords

  • alendronate
  • capture the Fracture (R) Best Practice Framework
  • Medication dispensation
  • P1NP
  • pharmacy deliveries
  • s-CTX
  • RANDOMIZED CONTROLLED-TRIAL
  • OSTEOPOROSIS MEDICATION
  • POSTMENOPAUSAL OSTEOPOROSIS
  • PRACTICE FRAMEWORK
  • ADHERENCE
  • PREVENTION
  • WOMEN
  • INTERVENTIONS
  • NETHERLANDS
  • EDUCATION

Cite this